Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

Young Canadian innovators take centre stage tomorrow as part of Canadian Innovation Week. The honourees, aged 14 to 18, are national winners and finalists of the Rideau Hall Foundation's (RHF) ...

Cancer remains one of the foremost public health challenges of the 21st century, characterized by remarkable heterogeneity in its incidence, mortality, and ...